Market cap
$33,061 Mln
Revenue (TTM)
$5,653 Mln
P/E Ratio
22.1
P/B Ratio
5.1
Div. Yield
1 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 2.25 | 8.58 | 9.85 | 10.21 | 12.08 |
| EBIT | -7.86 | 3.52 | 15.44 | 19.28 | 16.31 |
| Net Profit | -3.84 | 0.98 | 8.75 | 19.59 | 26.67 |
| EPS | -2.47 | 2.42 | 9.37 | 19.51 | 26.27 |
| Book Value | -- | -- | 11.92 | 17.52 | 18.20 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Jun-26 | Jun-25 | Jun-24 |
| EBIT-Margin
| 31.73 | 30.03 | 34.46 | 32.60 | 28.12 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 24.28 | 24.35 | 24.27 | 25.86 | 22.70 |
| Return on Capital
| 20.52 | 19.82 | 21.41 | 22.31 | 17.84 |
| Return on Assets
| 17.13 | 16.48 | 17.77 | 18.62 | 14.99 |
| Debt to Equity (x)
| -- | -- | 0.13 | 0.14 | 0.18 |
Profitability
ROCE
21.41
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
21.41
|
22.31
|
17.84
|
17.97
|
19.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
24.27
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
24.27
|
25.86
|
22.70
|
23.96
|
24.96
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
17.77
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
17.77
|
18.62
|
14.99
|
15.15
|
15.87
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
34.46
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
34.46
|
32.60
|
28.12
|
27.52
|
27.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
26.94
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
26.94
|
27.22
|
21.79
|
21.25
|
21.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.10
--
Year on year growth in net sales
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
0.10
|
0.10
|
0.11
|
0.18
|
0.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
16.15
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
16.15
|
27.35
|
13.34
|
18.26
|
7.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
8.75
--
Year on year growth in profit after tax
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
8.75
|
37.20
|
13.75
|
15.15
|
64.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.10
--
Year on year growth in earnings per share
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
0.10
|
0.38
|
0.14
|
0.15
|
0.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.13
--
Total debt / Net worth
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
0.13
|
0.14
|
0.18
|
0.38
|
0.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.04
--
(Short term borrowings / Net worth)
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
0.04
|
0.01
|
0.01
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
3.10
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
3.10
|
3.44
|
2.59
|
3.12
|
2.80
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
2.42
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
2.42
|
2.53
|
1.69
|
1.81
|
1.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
67.12
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
67.12
|
133.05
|
28.82
|
24.53
|
44.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
18.33
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
18.33
|
19.25
|
17.87
|
16.69
|
16.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.66
--
Sales / Average Total Assets
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
0.66
|
0.68
|
0.69
|
0.71
|
0.73
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
65.48
--
Average Debtors / Sales * 365
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
65.48
|
64.87
|
60.11
|
55.39
|
61.31
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
155.82
--
Average Inventory / Sales * 365
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
155.82
|
152.81
|
163.76
|
170.36
|
141.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
48.83
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
48.83
|
45.05
|
34.95
|
30.32
|
34.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
172.47
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
172.47
|
172.63
|
188.92
|
195.43
|
167.52
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
18.55
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
18.55
|
27.08
|
27.66
|
35.92
|
39.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
4.29
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
4.29
|
6.36
|
5.81
|
7.81
|
9.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
12.86
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Jun-26
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
|---|---|---|---|---|---|
|
ResMed (RMD)
|
12.86
|
19.63
|
18.82
|
24.71
|
26.73
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|